Immune Design Corp. Licenses Revenue (Deprecated 2018-01-31)
Immune Design Corp. reported Licenses Revenue (Deprecated 2018-01-31) of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-14.
Discontinued › Income Statement › Other Income
us-gaap:LicensesRevenue · last filed 2018-03-14
- Immune Design Corp. licenses revenue (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $0.00.
- Immune Design Corp. licenses revenue (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- Immune Design Corp. licenses revenue (deprecated 2018-01-31) for the quarter ending 2016-12-31 was $0.00.
- Immune Design Corp. licenses revenue (deprecated 2018-01-31) for the quarter ending 2016-09-30 was $7.00M, a 100.00% increase year-over-year.
- Immune Design Corp. licenses revenue (deprecated 2018-01-31) for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Immune Design Corp. licenses revenue (deprecated 2018-01-31) for fiscal 2016 was $7.00M, a 100.00% increase from fiscal 2015.
- Immune Design Corp. licenses revenue (deprecated 2018-01-31) for fiscal 2015 was $3.50M, a 22.22% decline from fiscal 2014.
- Immune Design Corp. licenses revenue (deprecated 2018-01-31) for fiscal 2014 was $4.50M, a 517.28% increase from fiscal 2013.
| Period end | Licenses Revenue (Deprecated 2018-01-31) 3 month | Licenses Revenue (Deprecated 2018-01-31) 6 month | Licenses Revenue (Deprecated 2018-01-31) 9 month | Licenses Revenue (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $0.00 derived: sum of 2 quarters · filed 2018-03-14 | $0.00 10-K · filed 2018-03-14 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-01 | $0.00 10-Q · filed 2017-11-01 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $7.00M derived: sum of 2 quarters · filed 2018-03-14 | $7.00M 10-K · filed 2018-03-14 | |
| 2016-09-30 | $7.00M 10-Q · filed 2017-11-01 | $7.00M 10-Q · filed 2017-11-01 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $3.50M derived: sum of 2 quarters · filed 2018-03-14 | $3.50M derived: sum of 3 quarters · filed 2018-03-14 | $3.50M 10-K · filed 2018-03-14 |
| 2015-09-30 | $3.50M 10-Q · filed 2016-11-09 | $3.50M derived: sum of 2 quarters · filed 2016-11-09 | $3.50M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-12 | $0.00 10-Q · filed 2015-08-12 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | $3.50M derived: sum of 2 quarters · filed 2017-03-07 | $4.50M derived: sum of 3 quarters · filed 2017-03-07 | $4.50M 10-K · filed 2017-03-07 |
| 2014-09-30 | $3.50M 10-Q · filed 2015-11-12 | $4.50M derived: sum of 2 quarters · filed 2015-11-12 | $4.50M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $1.00M 10-Q · filed 2015-08-12 | $1.00M 10-Q · filed 2015-08-12 | ||
| 2013-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $25.00K derived: sum of 2 quarters · filed 2016-03-15 | $539.00K derived: sum of 3 quarters · filed 2016-03-15 | $729.00K 10-K · filed 2016-03-15 |
| 2013-09-30 | $13.00K 10-Q · filed 2014-11-13 | $527.00K derived: sum of 2 quarters · filed 2014-11-13 | $717.00K 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $514.00K 10-Q · filed 2014-09-08 | $704.00K 10-Q · filed 2014-09-08 | ||
| 2012-12-31 | $876.00K 10-K · filed 2015-03-31 |